Adage Capital Partners
ARRY

Adage Capital Partners’s Array Biopharma Inc ARRY Stock Holding History

Adage Capital Partners’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-20,000
Closed -$927K – 784
2019
Q2 		$927K Buy
+20,000
New +$562K ﹤0.01% 683

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Adage Capital Partners's ARRY Position: Q3 2019 in Review

Adage Capital Partners sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 20,000 shares — an estimated $927K sold.

Adage Capital Partners first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $927K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Adage Capital Partners reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Adage Capital Partners sold 20,000 Array Biopharma Inc shares in Q3 2019, an estimated $927K.
  • Adage Capital Partners first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Adage Capital Partners's Array Biopharma Inc position peaked at $927K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Adage Capital Partners's 13F filing for Q3 2019, filed 14 Nov 2019.